Description of Collaborative Activity: |
NVPO provided personnel in a Detail Assignment to support the following activities: 1. Guide and assist with National Institute of Allergy and Infectious Diseases (NIAID) Emerging Infectious Disease (EID) Outbreak Research Reponse; 2. Direct strategic planning and advance development for the VRC's expanding portfolio of candidate vaccines and biotherapeutics; 3. Lead maternal immunization clinical research and vaccine safety surveying and monitoring for VRC's EID Outbreak Research Response to the Zika virus epidemic, and other vaccine candidates being developed at the VRC; 4. Facilitate collaborative efforts with stakeholders, NIAID, Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), academic institutions, private organizations, and industries dedicated to expanding the state of knowledge of vaccine health globally, to enhance research and clinical readiness; 5. Facilitate advancement of a national strategy to develop medical products and strategies to counter emerging and re-emerging infectious diseases. |
